Evidence map›Paper›PMID 36882747›Full record

ArticleBMC pulmonary medicine2023

Heterogeneous uptake of

Yuan Hu, Peng Wang, Wenli Dai

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC pulmonary medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yuan HuDepartment of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443003, Hubei, China.
Peng WangDepartment of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443003, Hubei, China.
Wenli DaiDepartment of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443003, Hubei, China. daiwenli@ctgu.edu.cn.
China Three Gorges University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPSMA PET/CT has shown excellent results in imaging of prostate cancer. However, some nonprostatic malignancies can also demonstrate CASE PRESENTATION: A 70-year-old male underwent

conclusionIn this case, there was a homogeneity of

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsProstatic NeoplasmsAgedFluorodeoxyglucose F18HumansLymphatic MetastasisMaleNiacinamideOligopeptidesPositron Emission Tomography Computed TomographyTumor MicroenvironmentFluorodeoxyglucose F18NiacinamideOligopeptidesPSMA-100718F-FDG18F-PSMA-1007Lymph node metastasesPET/CTPrimary lung cancer

Identifiers

PMID36882747
PMCPMC9993722
OpenAlexW4323535714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.